Literature DB >> 16299032

Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

D E J Jones1, N Bhala, J Burt, J Goldblatt, M Prince, J L Newton.   

Abstract

BACKGROUND AND AIMS: Fatigue is the commonest symptom described by patients in most populations with the autoimmune liver disease primary biliary cirrhosis (PBC), and appears to be unrelated to liver disease severity. At present, it is unclear how the fatigue experienced by patients (only characterised to date in cross sectional studies) evolves over time. In this study, we set out to address how fatigue had changed over four years of follow up in a geographically defined cohort of PBC patients who participated in an earlier cross sectional study of fatigue impact.
METHODS: Participants in the original 2000 study who were still alive in 2004 were asked to complete the same fatigue assessment tool (fatigue impact score, FIS). In those who had died between 2000 and 2004, medical notes, death certificates, and primary care records were reviewed.
RESULTS: A total of 108 of the original cohort of 136 patients were alive at the time of the follow up study, 99 of whom (92%) participated in the follow up study. With the exception of four patients who underwent transplantation between 2000 and 2004, all of whom showed significant improvement in fatigue severity as assessed by FIS, fatigue severity was unchanged over four years of follow up. Among the 28 patients who died during the follow up period, survival was significantly lower in patients who were fatigued at the 2000 baseline (FIS above the median for the whole PBC population (40/160); log rank test, p = 0.006 v non-fatigued patients at baseline). Increased fatigue severity was independently associated with decreased survival on multivariate analysis. Fatigued PBC subjects were significantly more likely to have suffered a cardiac death than non-fatigued patients.
CONCLUSIONS: The fatigue phenotype appears to be highly stable in PBC. The presence of fatigue in PBC is independently associated with a significantly increased risk of death in general, and cardiac death in particular. Factors underpinning fatigue in PBC, and the mechanisms whereby fatigue is associated with increased mortality, warrant further study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299032      PMCID: PMC1856154          DOI: 10.1136/gut.2005.080317

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Fatigue in MS is related to sympathetic vasomotor dysfunction.

Authors:  P Flachenecker; A Rufer; I Bihler; C Hippel; K Reiners; K V Toyka; J Kesselring
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

2.  Assessing quality of life in primary biliary cirrhosis.

Authors:  Anne Rannard; Deborah Buck; David E J Jones; Oliver F W James; Ann Jacoby
Journal:  Clin Gastroenterol Hepatol       Date:  2004-02       Impact factor: 11.382

Review 3.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  J Hepatol       Date:  2003-10       Impact factor: 25.083

4.  The true impact of fatigue in primary biliary cirrhosis: a population study.

Authors:  Jennifer Goldblatt; Philip J S Taylor; Toby Lipman; Martin I Prince; Anna Baragiotta; Margaret F Bassendine; Oliver F W James; David E J Jones
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome.

Authors:  Arnold Peckerman; John J LaManca; Bushra Qureishi; Kristina A Dahl; Roseli Golfetti; Yoshiharu Yamamoto; Benjamin H Natelson
Journal:  Psychosom Med       Date:  2003 Sep-Oct       Impact factor: 4.312

6.  Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.

Authors:  Martin Prince; Amanda Chetwynd; Wendy Newman; Jane V Metcalf; Oliver F W James
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

7.  Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial.

Authors:  M I Prince; H C Mitchison; D Ashley; D A Burke; N Edwards; M G Bramble; O F W James; D E J Jones
Journal:  Aliment Pharmacol Ther       Date:  2003-01       Impact factor: 8.171

8.  Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.

Authors:  D M Forton; N Patel; M Prince; A Oatridge; G Hamilton; J Goldblatt; J M Allsop; J V Hajnal; H C Thomas; M Bassendine; D E J Jones; S D Taylor-Robinson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

9.  Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.

Authors:  M Longo; A Crosignani; P M Battezzati; C Squarcia Giussani; P Invernizzi; M Zuin; M Podda
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].

Authors:  Pieter C J ter Borg; Erik van Os; Walter W van den Broek; Bettina E Hansen; Henk R van Buuren
Journal:  BMC Gastroenterol       Date:  2004-07-13       Impact factor: 3.067

View more
  21 in total

Review 1.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

Review 2.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

Review 3.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

4.  Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease.

Authors:  Iliana Doycheva; Chaoru Chen; Jen-Jung Pan; Cynthia Levy
Journal:  World J Hepatol       Date:  2011-04-27

5.  Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Jennifer Y Lee; Christopher J Danford; Hirsh D Trivedi; Elliot B Tapper; Vilas R Patwardhan; Alan Bonder
Journal:  Dig Dis Sci       Date:  2019-01-10       Impact factor: 3.199

Review 6.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

7.  Quality of life and everyday activities in patients with primary biliary cirrhosis.

Authors:  Carlo Selmi; M Eric Gershwin; Keith D Lindor; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Pietro Invernizzi; Marshall M Kaplan; John M Vierling; Christopher L Bowlus; Marina G Silveira; Ilaria Bossi
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 8.  Clinical features and management of primary biliary cirrhosis.

Authors:  Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.

Authors:  Marion G Peters; Adrian M Di Bisceglie; Kris V Kowdley; Nancy L Flye; Velimir A Luketic; Santiago J Munoz; Guadalupe Garcia-Tsao; Thomas D Boyer; John R Lake; Maurizio Bonacini; Burton Combes
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

Review 10.  The unfinished business of primary biliary cirrhosis.

Authors:  Carlo Selmi; Massimo Zuin; M Eric Gershwin
Journal:  J Hepatol       Date:  2008-07-02       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.